Spiking’s Post

View organization page for Spiking, graphic

2,978 followers

Have you heard of Chromocell Therapeutics Corporation (NYSE American: CHRO)? 🤔 They just closed their initial public offering of 1,100,000 shares of their common stock at $6.00 per share, raising approximately $6.6 million. 💰 That’s a huge milestone for Chromocell Corporation. 🚀 They are a clinical-stage biotech company that is developing and commercializing new, non-opioid therapeutics to alleviate pain. 💊 This post is brought to you by Spiking Wealth Masterclass. Sign up for Early Bird at $0 now: https://spi.ke/mc25 They have a novel approach to target the sodium ion-channel known as NaV1.7, which is involved in various types of chronic neuropathic pain and eye pain. 👁️ They also have pre-clinical work on other sodium channel receptor subtypes and plan to explore them for the treatment of additional pain indications. 🔬 To get more updates on IPO, stock market, investment, and crypto currency, Follow Us! 😊 Also, don’t miss this chance to join the Spiking community and become a smart investor. 😎 Dr. Clemen Chiang (PhD, MBA) #CHRO #NYSE #IPO #Investing #Finance #FinancialEducation #FinancialSuccess #FinancialLiteracy #Trading #Spiking

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics